© The Author 2006. Published by Oxford University Press.
ARTICLE |
Autoimmunity and Susceptibility to Hodgkin Lymphoma: A Population-Based Case–Control Study in Scandinavia
Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (OL, EAE, RMP, GG, KFK, MSL, LRG); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (LM, JHO); Information Management Services Inc, Rockville, MD (WW); Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden (KH); Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany (KH)
Correspondence to: Ola Landgren, MD, PhD, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health & Human Services, 6120 Executive Blvd., Bldg. EPS/Room 7110, Bethesda, MD 20892-7236 (e-mail: landgreo{at}mail.nih.gov).
Background: Personal history of autoimmune diseases is consistently associated with increased risk of non-Hodgkin lymphoma. In contrast, there are limited data on risk of Hodgkin lymphoma following autoimmune diseases and almost no data addressing whether there is a familial association between the conditions. Methods: Using population-based linked registry data from Sweden and Denmark, 32 separate autoimmune and related conditions were identified from hospital diagnoses in 7476 case subjects with Hodgkin lymphoma, 18 573 matched control subjects, and more than 86 000 first-degree relatives of case and control subjects. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) as measures of relative risks for each condition using logistic regression and also applied multivariable hierarchical regression models. All P values are two-sided. Results: We found statistically significantly increased risks of Hodgkin lymphoma associated with personal histories of several autoimmune conditions, including rheumatoid arthritis (OR = 2.7, 95% CI = 1.9 to 4.0), systemic lupus erythematosus (OR = 5.8, 95% CI = 2.2 to 15.1), sarcoidosis (OR = 14.1, 95% CI = 5.4 to 36.8), and immune thrombocytopenic purpura (OR = 
, P = .002). A statistically significant increase in risk of Hodgkin lymphoma was associated with family histories of sarcoidosis (OR = 1.8, 95% CI = 1.01 to 3.1) and ulcerative colitis (OR = 1.6, 95% CI = 1.02 to 2.6). Conclusions: Personal or family history of certain autoimmune conditions was strongly associated with increased risk of Hodgkin lymphoma. The association between both personal and family histories of sarcoidosis and a statistically significantly increased risk of Hodgkin lymphoma suggests shared susceptibility for these conditions.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M Gayed, S Bernatsky, R Ramsey-Goldman, A. Clarke, and C Gordon Lupus and cancer Lupus, May 1, 2009; 18(6): 479 - 485. [Abstract] [PDF]
|
|
|
|
 |
|
 E. T. Chang, B. M. Birmann, J. L. Kasperzyk, D. V. Conti, P. Kraft, R. F. Ambinder, T. Zheng, and N. E. Mueller Polymorphic Variation in NFKB1 and Other Aspirin-Related Genes and Risk of Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 976 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, X. Li, J. Sundquist, and K. Sundquist Cancer risks in Crohn disease patients Ann. Onc., March 1, 2009; 20(3): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koshiol, G. Gridley, E. A. Engels, M. L. McMaster, and O. Landgren Chronic Immune Stimulation and Subsequent Waldenstrom Macroglobulinemia Arch Intern Med, September 22, 2008; 168(17): 1903 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, X. Li, K. Sundquist, and J. Sundquist Cancer risk in hospitalized rheumatoid arthritis patients Rheumatology, May 1, 2008; 47(5): 698 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hemminki, X. Li, K. Sundquist, and J. Sundquist Shared familial risk factors between cancer and RA patients Rheumatology, April 1, 2008; 47(4): 549 - 551. [Full Text] [PDF]
|
|
|
|
 |
|
 O. Landgren, J. S. Rapkin, N. E. Caporaso, L. Mellemkjaer, G. Gridley, L. R. Goldin, and E. A. Engels Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia Blood, March 1, 2007; 109(5): 2198 - 2201. [Abstract] [Full Text] [PDF]
|
|